2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Neoplasms, Pleural in 3 studies
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mikami, I | 1 |
Zhang, F | 1 |
Hirata, T | 1 |
Okamoto, J | 1 |
Koizumi, K | 1 |
Shimizu, K | 1 |
Jablons, D | 1 |
He, B | 1 |
Miyoshi, S | 1 |
Hamada, H | 1 |
Hamaguchi, N | 1 |
Kato, A | 1 |
Katayama, H | 1 |
Irifune, K | 1 |
Ito, R | 1 |
Miyazaki, T | 1 |
Okura, T | 1 |
Higaki, J | 1 |
Mukohara, T | 1 |
Civiello, G | 1 |
Johnson, BE | 1 |
Janne, PA | 1 |
3 other studies available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Neoplasms, Pleural
Article | Year |
---|---|
Inhibition of activated phosphatidylinositol 3-kinase/AKT pathway in malignant pleural mesothelioma leads to G1 cell cycle arrest.
Topics: Cell Cycle; Cell Line, Tumor; Cell Proliferation; Chromones; Down-Regulation; Drug Evaluation, Precl | 2010 |
Antitumor activity of MEK and PI3K inhibitors against malignant pleural mesothelioma cells in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Butadienes; Cell Proliferation; Chromones; Drug Synergism | 2012 |
Therapeutic targeting of multiple signaling pathways in malignant pleural mesothelioma.
Topics: Antibiotics, Antineoplastic; Butadienes; Cell Cycle; Chromones; Enzyme Inhibitors; ErbB Receptors; G | 2005 |